Mayank Goyal (Canada)
University of Calgary
Radiology
Mayank Goyal is a Professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary. He also holds the Heart and Stroke Foundation Chair in Stroke Research. He has led multiple global trials in the acute stroke space such as ESCAPE, SWIFT PRIME and ESCAPE-NA1 trial. He is also the Chair of the HERMES collaboration. He has over 300 publications in peer-reviewed journals. He is the inventor of the imaging technique multiphase CTA. Mayank loves teaching and travels extensively around the world helping with stroke care organization, workflow, imaging and intervention. He is also the Founder and President of a web-based platform to accelerate stroke research: www.collavidence.com

Presenter of 4 Presentations

 Congress Calendar

Going further…and beyond.

Session Name
1090 - SPONSORED SYMPOSIUM 03 (Not Included In The Main Event CME/CPD Credit) (ID 341)
Session Type
Industry
Date
Thu, 27.10.2022
Session Time
12:00 - 13:00
Room
Summit 1
Presenter
Lecture Time
12:20 - 12:40

Quick Imaging Assessment for Reperfusion Decision Making

Session Name
0730 - Teaching Course 03: Imaging Concepts in Stroke (ID 312)
Session Type
Acute Stroke Treatment
Date
Wed, 26.10.2022
Session Time
13:30 - 15:00
Room
Room 324-325
Presenter
Lecture Time
13:55 - 14:15

How Clot Imaging Could Help Thrombectomy?

Session Name
0550 - ONSITE AND LIVE STREAMED SESSION - Retrieving the Clot – Achieving the Task (ID 304)
Session Type
Acute Stroke Treatment
Date
Wed, 26.10.2022
Session Time
10:00 - 11:30
Room
Hall 406
Presenter
Lecture Time
10:19 - 10:36

BRIDGING THE FUNDING GAP: A NOVEL COLLABORATIVE ONLINE PLATFORM FOR STROKE RESEARCH FUNDING

Session Name
0450 - E-Poster Viewing: AS42 Other Topics (ID 453)
Session Type
E-Poster
Date
Wed, 26.10.2022
Session Time
07:00 - 23:59
Room
GALLERY
Presenter
Lecture Time
07:00 - 07:00

Abstract

Background and Aims

The current stroke research funding environment is highly competitive, stifling collaboration and hindering progress. Further, specific groups of researchers/research topics are disproportionately affected, resulting in inequity in the funding process (e.g., early-career-researchers (ECR), women, and researchers from low-middle-income countries, rare stroke-related diseases). Currently, there is no easy way for people working on such topics to collaborate. To address this problem, a novel internet-based platform, Collavidence (www.collavidence.com), was designed. The idea is to complement current systems of stroke research collaboration and funding for more inclusive, efficient, and impactful research results. The aim of this study is to present the initial performance of the platform in achieving this goal.

Methods

User engagement will be assessed by weekly registration rate in the first six months following launch of the platform (March 30th, 2022), as well as the number of projects posted, the amount of funding accumulated, the proportion of successfully funded projects, and the iterative improvement of the proposals. Further, the relative engagement of ECR, female researchers, and researchers from low-middle-income countries will be assessed and presented in comparison to traditional granting agencies.

Results

Qualitative assessment of the value of the overall platform, the process of iterative review, and possibilities for collaboration will be presented. Trends in the first six months of platform engagement and the relative distribution of specific user demographics, to assess the platform’s success in encouraging equity, diversity, and inclusion, will be discussed.

Conclusions

This study will discuss the feasibility of Collavidence as a unique platform for stroke research collaboration and funding.

Hide